Breaking Boundaries in a Series B Financing

Silverback Therapeutics

At the time of its Series B Financing, Silverback Therapeutics was a maturing biopharma company that had advanced significantly since its previous round of fundraising. We delivered on a comprehensive communications strategy that enabled Silverback to tell its new story, including media relations, editorial refinement and social media development.

Canale Communications ©2021